Gynoflor was tested as a management tool for post-antibiotic or anti-fungal treatments for bacterial vaginosis, yeast infections and trichomoniasis, and was reasonably successful at least in the short-term.
Malignant changes estrogen-dependent tumours in the breast, uterus or vagina; endometriosis suspected or manifested ; vaginal haemorrhaging of unknown origin.